UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Risk parity assigns capital to balance risk contributions across asset classes in retirement portfolios, aiming for steadier, more resilient returns.
26,593 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
A Microsoft AI diffusion report reveals AI usage climbing across all states, with Texas outpacing California and nont...
Bitwise argues that investors have not fully priced Hyperliquid's expansion into a multi-asset platform and the value...
Shoe Carnival's Q1 2026 results offer early clues about its path through promotions, online growth, and inventory man...
Barnes Noble clarifies Bookseller’s AI policy, saying it will not ban AI-written titles but will require clear labeli...
A new AI coaching platform is launching to give every loan officer a personalized, on-demand coach. Early pilots show...
Box Inc is set to release Q1 results after the bell, with investors watching AI monetization progress and insider sel...
Stellantis has laid out a multi-year, multi-pillar plan to reboot profitability. The real value may come from a surpr...
Duke University researchers unveiled Argus, a 20-legged robot capable of moving in any direction. The breakthrough co...
MongoDB is set to release its Q1 results after the bell, with investors looking for Atlas expansion, solid cash flow,...
Dell Technologies beats expectations, validating its AI-focused partnership with Palantir and sending Palantir shares...
Eight senior researchers have left the Ethereum Foundation since January 2026, signaling a pivotal governance clash a...